This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Krisha K Raina
Introduction
Krisha K Raina is a notable inventor based in Maharashtra, India. She has made significant contributions to the field of biotechnology, particularly in the preparation of insulin. Her innovative approach has the potential to enhance the efficiency of insulin production, which is crucial for diabetes management.
Latest Patents
Krisha K Raina holds a patent for a method for the preparation of insulin by cleavage of a fusion protein. This invention provides a protein precursor of a double-chain molecule that consists of at least two polypeptide chains linked by two disulfide bonds. The precursor has the general formula B—Z—A, where B and A represent the two insulin polypeptide chains, and Z is a polypeptide that includes at least one site for proteolytic cleavage. This method allows for the production of a secreted double-chain product consisting of disulfide-bonded A and B chains, which can be further processed to isolate mature insulin.
Career Highlights
Throughout her career, Krisha K Raina has demonstrated a strong commitment to advancing biotechnological methods. Her work has not only contributed to scientific knowledge but also holds promise for practical applications in medicine. With her innovative patent, she has positioned herself as a key player in the field of insulin production.
Collaborations
Krisha has collaborated with notable colleagues, including Peter A Meacock and Candadai Seshardi Ramadoss. These partnerships have likely enriched her research and contributed to the success of her innovative projects.
Conclusion
Krisha K Raina's contributions to the field of biotechnology, particularly in insulin preparation, highlight her role as an influential inventor. Her innovative methods have the potential to significantly impact diabetes treatment and improve the lives of many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile